{"id":59473,"date":"2024-02-28T05:59:35","date_gmt":"2024-02-28T05:59:35","guid":{"rendered":"https:\/\/medsname.com\/niftas\/"},"modified":"2026-04-30T11:50:31","modified_gmt":"2026-04-30T11:50:31","slug":"niftas","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/niftas\/","title":{"rendered":"Niftas"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 Quick Answer \u2014 What is Niftas?<\/h3>\n

Niftas is a nitrofurantoin tablet for uncomplicated lower UTI in women. NOT for pyelonephritis. Avoid in CrCl < 45. Manufactured under WHO-GMP standards.<\/p>\n<\/div>\n

Pro\u010d objedn\u00e1vat z MedsBase?<\/strong> Dod\u00e1v\u00e1no od v\u00fdrobce certifikovan\u00e9ho WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Doprava po cel\u00e9m sv\u011bt\u011b \u00b7 1 400+ ov\u011b\u0159en\u00fdch recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n

\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n

Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n

Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n

P\u0159ehled produktu<\/strong><\/h2>\n

Niftas is a medication containing the active ingredient Nitrofurantoin. It belongs to a class of antibiotics known as nitrofurans and is primarily used to treat urinary tract infections (UTIs) caused by certain bacteria. Available in both oral capsule and suspension forms, Niftas works by inhibiting the growth and reproduction of bacteria responsible for UTIs. It is commonly prescribed for both acute and chronic UTIs, providing effective relief from symptoms such as painful urination, frequent urination, and lower abdominal pain.<\/p>\n

Pou\u017eit\u00ed<\/strong><\/h2>\n

Niftas is indicated for the treatment of urinary tract infections caused by susceptible strains of bacteria, including Escherichia coli, Enterococcus species, and Staphylococcus aureus. It is effective against both lower and upper urinary tract infections, including cystitis and pyelonephritis. Niftas works by interfering with the synthesis of bacterial cell walls, leading to bacterial cell death and resolution of the infection. It is often prescribed as a first-line treatment for uncomplicated UTIs due to its efficacy and low risk of resistance.<\/p>\n

Jak pou\u017e\u00edvat<\/strong><\/h2>\n

Niftas is usually taken orally with a full glass of water, preferably with food to minimize gastrointestinal side effects. The dosage and duration of treatment will depend on the severity of the infection and the patient’s age and renal function. It is important to take Niftas exactly as prescribed by a healthcare professional and to complete the full course of treatment, even if symptoms improve before the medication is finished. Failure to do so may result in the recurrence of the infection or development of antibiotic resistance.<\/p>\n

Jak p\u016fsob\u00ed<\/strong><\/h2>\n

Nitrofurantoin, the active ingredient in Niftas, works by inhibiting the synthesis of bacterial cell walls, ultimately leading to bacterial cell death. It exerts its bactericidal effects by interfering with multiple enzymatic processes involved in the production of bacterial cell wall components. Additionally, Nitrofurantoin is capable of damaging bacterial DNA, further contributing to its antimicrobial activity. By targeting key components of bacterial cell structure and function, Niftas effectively eliminates the bacteria responsible for urinary tract infections.<\/p>\n

D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/strong><\/h2>\n

The recommended dosage of Niftas for uncomplicated urinary tract infections in adults is usually 50 to 100 mg orally four times daily for 7 days. For the prevention of recurrent urinary tract infections, a lower dosage of 50 to 100 mg orally at bedtime is often prescribed. Dosage adjustments may be necessary for patients with renal impairment, as Nitrofurantoin is primarily eliminated by the kidneys. It is important to follow the dosage instructions provided by a healthcare professional to ensure optimal treatment outcomes.<\/p>\n

V\u00fdhody<\/strong><\/h2>\n

Niftas offers several benefits for patients with urinary tract infections. It provides effective relief from symptoms such as dysuria, urgency, and frequency associated with UTIs, improving the patient’s quality of life. Niftas is generally well-tolerated and has a low risk of systemic side effects compared to other antibiotics. Its broad spectrum of activity and convenient dosing regimen make it a preferred choice for the treatment and prevention of urinary tract infections.<\/p>\n

B\u011b\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky<\/strong><\/h2>\n

Common side effects of Niftas may include nausea, vomiting, diarrhea, abdominal pain, and headache. These side effects are usually mild and transient, resolving on their own without the need for medical intervention. However, if any side effects persist or worsen, it is important to consult a healthcare professional for further evaluation and management.<\/p>\n

Varov\u00e1n\u00ed<\/strong><\/h2>\n

Niftas should be used with caution in patients with known hypersensitivity to Nitrofurantoin or any other components of the formulation. It is contraindicated in patients with renal impairment, hepatic impairment, or a history of cholestatic jaundice associated with Nitrofurantoin use. Long-term use of Niftas may increase the risk of antibiotic resistance and the development of drug-resistant bacteria. It is important to discuss the risks and benefits of Niftas with a healthcare professional before starting treatment.<\/p>\n

Informace o skladov\u00e1n\u00ed<\/strong><\/h2>\n

Store Niftas capsules and suspension at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Niftas beyond the expiration date printed on the packaging. If unused medication remains after completion of treatment, discard it properly according to local regulations.<\/p>\n

Odm\u00edtnut\u00ed odpov\u011bdnosti:<\/strong><\/h2>\n

Na\u0161\u00edm jedin\u00fdm z\u00e1m\u011brem je zajistit, aby spot\u0159ebitel\u00e9 z\u00edskali informace, kter\u00e9 jsou odborn\u011b ov\u011b\u0159en\u00e9, p\u0159esn\u00e9 a d\u016fv\u011bryhodn\u00e9. Informace zde obsa\u017een\u00e9 by v\u0161ak NEM\u011aLY b\u00fdt pou\u017e\u00edv\u00e1ny jako n\u00e1hrada za radu kvalifikovan\u00e9ho l\u00e9ka\u0159e. Informace poskytovan\u00e9 zde jsou pouze pro informa\u010dn\u00ed \u00fa\u010dely. Nemus\u00ed zahrnovat v\u0161echny mo\u017en\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky, l\u00e9kov\u00e9 interakce, varov\u00e1n\u00ed nebo upozorn\u011bn\u00ed. Pros\u00edm, pora\u010fte se se sv\u00fdm l\u00e9ka\u0159em a proberte v\u0161echny sv\u00e9 dotazy t\u00fdkaj\u00edc\u00ed se jak\u00e9hokoli onemocn\u011bn\u00ed nebo l\u00e9ku. Na\u0161\u00edm c\u00edlem je podporovat, nikoli nahrazovat, vztah mezi l\u00e9ka\u0159em a pacientem.<\/p>\n

\u010casto kladen\u00e9 dotazy<\/h2>\n

What is Niftas used for?<\/h3>\n

Niftas is nitrofurantoin \u2014 first-line for uncomplicated lower urinary tract infection (cystitis) in adults and older children. It concentrates in urine but achieves negligible tissue levels, so it is NOT used for pyelonephritis, prostatitis, or any non-urinary infection.<\/p>\n

Why is Niftas not used for kidney infection?<\/h3>\n

Nitrofurantoin does not achieve adequate tissue concentrations in the renal parenchyma. Pyelonephritis requires an agent that reaches systemic and renal-tissue levels (typically a fluoroquinolone, third-generation cephalosporin, or aminoglycoside).<\/p>\n

What is the typical course length?<\/h3>\n

5 days for acute uncomplicated cystitis (modern guidance, equivalent efficacy to 7-day courses with better tolerability). Long-term low-dose prophylaxis (50\u2013100 mg at night) may be used for recurrent UTI under specialist supervision.<\/p>\n

Is Niftas safe with reduced kidney function?<\/h3>\n

No \u2014 nitrofurantoin is contraindicated when creatinine clearance is below 45 mL\/min (some guidance accepts down to 30 mL\/min for short courses). Reduced renal function impairs urinary concentration AND raises systemic toxicity risk. Check renal function before each course in older patients.<\/p>\n

What serious side effects can Niftas cause with prolonged use?<\/h3>\n

Acute or chronic pulmonary fibrosis, chronic active hepatitis, and peripheral neuropathy \u2014 all rare but serious. Risk rises sharply with courses over 6 months. Annual review is mandatory if used for long-term prophylaxis.<\/p>\n

Why does Niftas turn my urine brown?<\/h3>\n

Brown or rust-coloured urine is a normal harmless effect of nitrofurantoin and its metabolites \u2014 not a sign of bleeding or kidney damage. It resolves within a few days of stopping the course.<\/p>\n

<\/p>\n

Other Anti-Infective Medications<\/h2>\n